Aytu Bioscience, Inc.

Aytu Bioscience, Inc.

Aytu Bioscience, Inc.

Overview
Date Founded

2002

Headquarters

373 Inverness Parkway,Suite 206,Englewood, CO 80112

Type of Company

Public

Employees (Worldwide)

75

Industries

Pharmaceuticals
Consumer Services

Company Description

Aytu BioScience, Inc. is a specialty pharmaceutical company, which focuses on identifying, acquiring, and commercializing novel products. Its products include Natesto, Tuzistram, ZolpiMist and MiOXSYS. The company was founded on August 9, 2002 and is headquartered in Englewood, CO.

Contact Data
Trying to get in touch with decision makers at Aytu Bioscience, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chairman of the Board & Chief Executive Officer

President & Director

Chief Financial Officer

Executive Vice President-Corporate Development

Executive Vice President-Commercial Operations

Vice President-Commercial Operations

Board of Directors

Chairman of the Board & Chief Executive Officer at Aytu Bioscience, Inc.

Chief Investment Officer at Armistice Capital LLC

Founder at Ampio Pharmaceuticals Inc.

President at EPI Health LLC

Founder at Tris Pharma, Inc.

President/Chief Compliance Officer at Alpha Advisors LLC - Florida

President & Director at Aytu Bioscience, Inc.

Paths to Aytu Bioscience, Inc.
Potential Connections via
Relationship Science
You
Aytu Bioscience, Inc.
Recent Transactions
Details Hidden

Aytu Bioscience, Inc. issued USD Common Stock - Bought Deal

Details Hidden

Aytu Bioscience, Inc. purchases Innovus Pharmaceuticals, Inc.

Details Hidden

Aytu Bioscience, Inc. raised money in a private placement transaction

Insider Transactions
Details Hidden
Transaction Advisors
Auditor

Advised onAytu Bioscience, Inc. issued Up to USD Common Stock

Investment Advisor

Advised onAytu Bioscience, Inc. raised money in a private placement transaction

Investment Advisor

Advised onAytu Bioscience, Inc. raised money in a private placement transaction

Attorney

Advised onAytu Bioscience, Inc. issued Up to USD Common Stock

Attorney

Advised onAytu Bioscience, Inc. issued Up to USD Common Stock

Head, Investment Banking/Underwritings

Advised onAytu Bioscience, Inc. issued Up to USD Common Stock

Advisors & Consultants
Publicist

Senior Vice President, Investors Relations at Tiberend Strategic Advisors, Inc.

Key Stats and Financials As of 2020
Market Capitalization
$110M
Total Enterprise Value
$31.4M
Earnings Per Share
$-3.01
Revenue
$27.6M
EBITDAMargin
-56.62%
Total Equity
$95M
EBITDA
$-15.6M
Net Profit
$-13.6M
Debt TEV
0.49x
TEVNet Income
-2.3x
Enterprise Value / Sales
1.13x
Total Debt
$15.5M
Three Year Compounded Annual Growth Rate Of Revenue
104.7%
Non-Profit Donations & Grants
Suppliers
Acerus Pharmaceuticals Corp. Medical Support Services | Mississauga, Canada

Acerus Pharmaceuticals Corp. engages in the development, manufacture, production, marketing, and distribution of women's and men's health products. It focuses on therapeutics for urology, hormone replacement therapy, and female dysfunction. Its products include Estrace, Natesto, Gynoflor, and Tefina. The company was founded by Bruce D. Brydon, Rolf K. Reininghaus, and Mark L. Thompson on September 9, 2008 and is headquartered in Mississauga, Canada.

Tris Pharma, Inc. Pharmaceuticals | Monmouth Junction, NJ

Tris Pharma, Inc. engages in the provision of specialty pharmaceutical cervices. It focuses on the development of pharmaceutical science and technology-based products. The company was founded by Ketan Mehta in 2000 and is headquartered in Monmouth Junction, NJ.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Aytu Bioscience, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Aytu Bioscience, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Aytu Bioscience, Inc..